Is TKNO or FTRE more profitable?

Fortrea has a net margin of -3.18% compared to Alpha Teknova's net margin of -38.37%. Fortrea's return on equity of 10.72% beat Alpha Teknova's return on equity. Company Net Margins Return on Equity Return on Assets Alpha Teknova -38.37% -24.94% -16.53% Fortrea -3.18% 10.72% 2.17%

Does the media prefer TKNO or FTRE?

In the previous week, Fortrea had 3 more articles in the media than Alpha Teknova. MarketBeat recorded 7 mentions for Fortrea and 4 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 0.77 beat Fortrea's score of 0.50 indicating that Alpha Teknova is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Teknova 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fortrea 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor MRVI or TKNO?

In the previous week, Alpha Teknova had 2 more articles in the media than Maravai LifeSciences. MarketBeat recorded 4 mentions for Alpha Teknova and 2 mentions for Maravai LifeSciences. Alpha Teknova's average media sentiment score of 0.77 beat Maravai LifeSciences' score of 0.00 indicating that Alpha Teknova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Maravai LifeSciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Alpha Teknova 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor TKNO or BLFS?

In the previous week, Alpha Teknova had 3 more articles in the media than BioLife Solutions. MarketBeat recorded 4 mentions for Alpha Teknova and 1 mentions for BioLife Solutions. Alpha Teknova's average media sentiment score of 0.77 beat BioLife Solutions' score of 0.76 indicating that Alpha Teknova is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Teknova 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioLife Solutions 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is TKNO or PSNL more profitable?

Alpha Teknova has a net margin of -38.37% compared to Personalis' net margin of -153.84%. Alpha Teknova's return on equity of -24.94% beat Personalis' return on equity. Company Net Margins Return on Equity Return on Assets Alpha Teknova -38.37% -24.94% -16.53% Personalis -153.84% -46.47% -35.30%

Does the media prefer TKNO or PSNL?

In the previous week, Alpha Teknova and Alpha Teknova both had 4 articles in the media. Alpha Teknova's average media sentiment score of 0.77 beat Personalis' score of 0.10 indicating that Alpha Teknova is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Teknova 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Personalis 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger earnings & valuation, AZTA or TKNO?

Alpha Teknova has lower revenue, but higher earnings than Azenta. Alpha Teknova is trading at a lower price-to-earnings ratio than Azenta, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Azenta $593.82M 2.86 -$55.76M -$2.76 N/A Alpha Teknova $40.52M 11.89 -$17.26M -$0.31 N/A

Is AZTA or TKNO more profitable?

Azenta has a net margin of -20.63% compared to Alpha Teknova's net margin of -38.37%. Azenta's return on equity of 1.18% beat Alpha Teknova's return on equity. Company Net Margins Return on Equity Return on Assets Azenta -20.63% 1.18% 0.97% Alpha Teknova -38.37% -24.94% -16.53%

Does the media refer more to AZTA or TKNO?

In the previous week, Azenta had 1 more articles in the media than Alpha Teknova. MarketBeat recorded 5 mentions for Azenta and 4 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 0.77 beat Azenta's score of 0.15 indicating that Alpha Teknova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Azenta 0 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Alpha Teknova 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Alpha Teknova (TKNO) Competitors

$8.99 +0.13 (+1.47%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$9.10 +0.11 (+1.17%)

As of 10/2/2026 07:39 PM Eastern

Compare

TKNO vs. FTRE, MRVI, BLFS, PSNL, and AZTA

Should you buy Alpha Teknova stock or one of its competitors? Alpha Teknova's main competitors and comparable companies include Fortrea (FTRE), Maravai LifeSciences (MRVI), BioLife Solutions (BLFS), Personalis (PSNL), and Azenta (AZTA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Alpha Teknova compare to Fortrea?

Alpha Teknova (NASDAQ:TKNO) and Fortrea (NASDAQ:FTRE) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.

13.8% of Alpha Teknova shares are owned by institutional investors. 13.2% of Alpha Teknova shares are owned by insiders. Comparatively, 0.7% of Fortrea shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Alpha Teknova has a beta of 0.85, indicating that its share price is 15% less volatile than the broader market. Comparatively, Fortrea has a beta of 1.93, indicating that its share price is 93% more volatile than the broader market.

In the previous week, Fortrea had 3 more articles in the media than Alpha Teknova. MarketBeat recorded 7 mentions for Fortrea and 4 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 0.77 beat Fortrea's score of 0.50 indicating that Alpha Teknova is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Teknova	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fortrea	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Alpha Teknova presently has a consensus price target of $8.00, suggesting a potential downside of 11.01%. Fortrea has a consensus price target of $22.00, suggesting a potential upside of 10.00%. Given Fortrea's higher possible upside, analysts clearly believe Fortrea is more favorable than Alpha Teknova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Fortrea	1 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.33

Alpha Teknova has higher earnings, but lower revenue than Fortrea. Alpha Teknova is trading at a lower price-to-earnings ratio than Fortrea, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Teknova	$40.52M	11.89	-$17.26M	-$0.31	N/A
Fortrea	$2.72B	0.70	-$986.20M	-$0.91	N/A

Fortrea has a net margin of -3.18% compared to Alpha Teknova's net margin of -38.37%. Fortrea's return on equity of 10.72% beat Alpha Teknova's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Teknova	-38.37%	-24.94%	-16.53%
Fortrea	-3.18%	10.72%	2.17%

Summary

Fortrea beats Alpha Teknova on 9 of the 16 factors compared between the two stocks.

How does Alpha Teknova compare to Maravai LifeSciences?

Maravai LifeSciences (NASDAQ:MRVI) and Alpha Teknova (NASDAQ:TKNO) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, risk, institutional ownership, valuation, earnings and analyst recommendations.

Maravai LifeSciences has a net margin of -37.07% compared to Alpha Teknova's net margin of -38.37%. Maravai LifeSciences' return on equity of -15.70% beat Alpha Teknova's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Maravai LifeSciences	-37.07%	-15.70%	-8.17%
Alpha Teknova	-38.37%	-24.94%	-16.53%

Alpha Teknova has lower revenue, but higher earnings than Maravai LifeSciences. Alpha Teknova is trading at a lower price-to-earnings ratio than Maravai LifeSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Maravai LifeSciences	$185.74M	11.04	-$130.77M	-$0.52	N/A
Alpha Teknova	$40.52M	11.89	-$17.26M	-$0.31	N/A

Maravai LifeSciences has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market. Comparatively, Alpha Teknova has a beta of 0.85, meaning that its stock price is 15% less volatile than the broader market.

50.3% of Maravai LifeSciences shares are owned by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are owned by institutional investors. 2.5% of Maravai LifeSciences shares are owned by company insiders. Comparatively, 13.2% of Alpha Teknova shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Alpha Teknova had 2 more articles in the media than Maravai LifeSciences. MarketBeat recorded 4 mentions for Alpha Teknova and 2 mentions for Maravai LifeSciences. Alpha Teknova's average media sentiment score of 0.77 beat Maravai LifeSciences' score of 0.00 indicating that Alpha Teknova is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Maravai LifeSciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alpha Teknova	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Maravai LifeSciences presently has a consensus price target of $6.83, suggesting a potential downside of 13.50%. Alpha Teknova has a consensus price target of $8.00, suggesting a potential downside of 11.01%. Given Alpha Teknova's stronger consensus rating and higher probable upside, analysts plainly believe Alpha Teknova is more favorable than Maravai LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Maravai LifeSciences	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Alpha Teknova beats Maravai LifeSciences on 10 of the 16 factors compared between the two stocks.

How does Alpha Teknova compare to BioLife Solutions?

Alpha Teknova (NASDAQ:TKNO) and BioLife Solutions (NASDAQ:BLFS) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

BioLife Solutions has a net margin of 53.29% compared to Alpha Teknova's net margin of -38.37%. BioLife Solutions' return on equity of 2.70% beat Alpha Teknova's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Teknova	-38.37%	-24.94%	-16.53%
BioLife Solutions	53.29%	2.70%	2.49%

In the previous week, Alpha Teknova had 3 more articles in the media than BioLife Solutions. MarketBeat recorded 4 mentions for Alpha Teknova and 1 mentions for BioLife Solutions. Alpha Teknova's average media sentiment score of 0.77 beat BioLife Solutions' score of 0.76 indicating that Alpha Teknova is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Teknova	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BioLife Solutions	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Alpha Teknova currently has a consensus price target of $8.00, suggesting a potential downside of 11.01%. BioLife Solutions has a consensus price target of $31.38, suggesting a potential downside of 15.88%. Given Alpha Teknova's stronger consensus rating and higher probable upside, analysts plainly believe Alpha Teknova is more favorable than BioLife Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
BioLife Solutions	0 Sell rating(s)	10 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.09

Alpha Teknova has a beta of 0.85, indicating that its share price is 15% less volatile than the broader market. Comparatively, BioLife Solutions has a beta of 1.82, indicating that its share price is 82% more volatile than the broader market.

BioLife Solutions has higher revenue and earnings than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than BioLife Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Teknova	$40.52M	11.89	-$17.26M	-$0.31	N/A
BioLife Solutions	$106.69M	17.10	-$4.59M	$1.16	32.16

13.8% of Alpha Teknova shares are held by institutional investors. Comparatively, 93.2% of BioLife Solutions shares are held by institutional investors. 13.2% of Alpha Teknova shares are held by insiders. Comparatively, 2.2% of BioLife Solutions shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

BioLife Solutions beats Alpha Teknova on 10 of the 16 factors compared between the two stocks.

How does Alpha Teknova compare to Personalis?

Alpha Teknova (NASDAQ:TKNO) and Personalis (NASDAQ:PSNL) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, earnings, risk and valuation.

In the previous week, Alpha Teknova and Alpha Teknova both had 4 articles in the media. Alpha Teknova's average media sentiment score of 0.77 beat Personalis' score of 0.10 indicating that Alpha Teknova is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Teknova	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Personalis	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Alpha Teknova has higher earnings, but lower revenue than Personalis. Alpha Teknova is trading at a lower price-to-earnings ratio than Personalis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Teknova	$40.52M	11.89	-$17.26M	-$0.31	N/A
Personalis	$69.65M	24.48	-$81.27M	-$1.09	N/A

13.8% of Alpha Teknova shares are owned by institutional investors. Comparatively, 61.9% of Personalis shares are owned by institutional investors. 13.2% of Alpha Teknova shares are owned by company insiders. Comparatively, 4.2% of Personalis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Alpha Teknova has a net margin of -38.37% compared to Personalis' net margin of -153.84%. Alpha Teknova's return on equity of -24.94% beat Personalis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Teknova	-38.37%	-24.94%	-16.53%
Personalis	-153.84%	-46.47%	-35.30%

Alpha Teknova has a beta of 0.85, suggesting that its share price is 15% less volatile than the broader market. Comparatively, Personalis has a beta of 2.32, suggesting that its share price is 132% more volatile than the broader market.

Alpha Teknova currently has a consensus target price of $8.00, indicating a potential downside of 11.01%. Personalis has a consensus target price of $14.54, indicating a potential downside of 10.71%. Given Personalis' higher probable upside, analysts plainly believe Personalis is more favorable than Alpha Teknova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Personalis	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.30

Summary

Alpha Teknova beats Personalis on 8 of the 15 factors compared between the two stocks.

How does Alpha Teknova compare to Azenta?

Azenta (NASDAQ:AZTA) and Alpha Teknova (NASDAQ:TKNO) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, valuation, earnings, dividends, analyst recommendations and risk.

Azenta currently has a consensus target price of $41.20, suggesting a potential upside of 6.32%. Alpha Teknova has a consensus target price of $8.00, suggesting a potential downside of 11.01%. Given Azenta's stronger consensus rating and higher possible upside, research analysts clearly believe Azenta is more favorable than Alpha Teknova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Azenta	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Azenta has a net margin of -20.63% compared to Alpha Teknova's net margin of -38.37%. Azenta's return on equity of 1.18% beat Alpha Teknova's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Azenta	-20.63%	1.18%	0.97%
Alpha Teknova	-38.37%	-24.94%	-16.53%

Azenta has a beta of 1.52, indicating that its stock price is 52% more volatile than the broader market. Comparatively, Alpha Teknova has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market.

Alpha Teknova has lower revenue, but higher earnings than Azenta. Alpha Teknova is trading at a lower price-to-earnings ratio than Azenta, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Azenta	$593.82M	2.86	-$55.76M	-$2.76	N/A
Alpha Teknova	$40.52M	11.89	-$17.26M	-$0.31	N/A

In the previous week, Azenta had 1 more articles in the media than Alpha Teknova. MarketBeat recorded 5 mentions for Azenta and 4 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 0.77 beat Azenta's score of 0.15 indicating that Alpha Teknova is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Azenta	0 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alpha Teknova	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

99.1% of Azenta shares are owned by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are owned by institutional investors. 10.9% of Azenta shares are owned by insiders. Comparatively, 13.2% of Alpha Teknova shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Azenta beats Alpha Teknova on 11 of the 16 factors compared between the two stocks.

Get Alpha Teknova News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TKNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TKNO vs. The Competition

Export

Metric	Alpha Teknova	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$481.99M	$10.65B	$7.15B	$13.28B
Dividend Yield	N/A	1.44%	2.54%	17.33%
P/E Ratio	-29.00	32.54	274.71	26.04
Price / Sales	11.89	109.34	656.46	105.16
Price / Cash	N/A	27.32	78.87	52.62
Price / Book	7.02	6.85	10.93	6.31
Net Income	-$17.26M	$57.48B	$3.51B	$362.16M
7 Day Performance	-3.64%	2.53%	-2.00%	-1.66%
1 Month Performance	29.91%	8.30%	-6.19%	-4.68%
1 Year Performance	59.40%	32.96%	8.03%	1.57%

Alpha Teknova Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TKNO Alpha Teknova	1.3468 of 5 stars	$8.99 +1.5%	$8.00 -11.0%	+59.4%	$481.99M	$40.52M	N/A	158	News Coverage
FTRE Fortrea	3.0354 of 5 stars	$19.92 -2.5%	$22.00 +10.5%	+111.6%	$1.89B	$2.72B	N/A	14,300	News Coverage Analyst Upgrade
MRVI Maravai LifeSciences	0.7258 of 5 stars	$7.16 -4.0%	$6.83 -4.5%	+155.7%	$1.86B	$185.74M	N/A	415
BLFS BioLife Solutions	2.4259 of 5 stars	$37.46 -1.6%	$31.38 -16.2%	+40.3%	$1.83B	$96.21M	32.31	155
PSNL Personalis	1.5903 of 5 stars	$16.16 -1.3%	$14.54 -10.0%	+121.8%	$1.70B	$69.65M	N/A	260

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TKNO) was last updated on 10/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alpha Teknova (TKNO) Competitors

TKNO vs. FTRE, MRVI, BLFS, PSNL, and AZTA

How does Alpha Teknova compare to Fortrea?

Summary

How does Alpha Teknova compare to Maravai LifeSciences?

Summary

How does Alpha Teknova compare to BioLife Solutions?

Summary

How does Alpha Teknova compare to Personalis?

Summary

How does Alpha Teknova compare to Azenta?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TKNO vs. The Competition

Alpha Teknova Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alpha Teknova (TKNO) Competitors

TKNO vs. FTRE, MRVI, BLFS, PSNL, and AZTA

How does Alpha Teknova compare to Fortrea?

Do insiders & institutionals hold more shares of TKNO or FTRE?

Which has more risk & volatility, TKNO or FTRE?

Does the media prefer TKNO or FTRE?

Do analysts prefer TKNO or FTRE?

Which has preferable valuation & earnings, TKNO or FTRE?

Is TKNO or FTRE more profitable?

Summary

How does Alpha Teknova compare to Maravai LifeSciences?

Is MRVI or TKNO more profitable?

Which has preferable earnings & valuation, MRVI or TKNO?

Which has more volatility & risk, MRVI or TKNO?

Do institutionals and insiders hold more shares of MRVI or TKNO?

Does the media favor MRVI or TKNO?

Do analysts recommend MRVI or TKNO?

Summary

How does Alpha Teknova compare to BioLife Solutions?

Is TKNO or BLFS more profitable?

Does the media favor TKNO or BLFS?

Do analysts rate TKNO or BLFS?

Which has more volatility & risk, TKNO or BLFS?

Which has preferable valuation and earnings, TKNO or BLFS?

Do insiders and institutionals hold more shares of TKNO or BLFS?

Summary

How does Alpha Teknova compare to Personalis?

Does the media prefer TKNO or PSNL?

Which has stronger earnings & valuation, TKNO or PSNL?

Do institutionals and insiders believe in TKNO or PSNL?

Is TKNO or PSNL more profitable?

Which has more volatility & risk, TKNO or PSNL?

Do analysts prefer TKNO or PSNL?

Summary

How does Alpha Teknova compare to Azenta?

Do analysts prefer AZTA or TKNO?

Is AZTA or TKNO more profitable?

Which has more volatility and risk, AZTA or TKNO?

Which has stronger earnings & valuation, AZTA or TKNO?

Does the media refer more to AZTA or TKNO?

Do institutionals & insiders hold more shares of AZTA or TKNO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TKNO vs. The Competition

Alpha Teknova Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools